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Background: Antiseptics are commonly used for the management of MDR (multiple drug resistance) pathogens in
hospitals. They play crucial roles in the infection control practices. Antiseptics are often used for skin antisepsis,
gauze dressing, preparation of anatomical sites for surgical procedure, hand sterilization before in contact with
an infected person, before an invasive procedure and as surgical scrub.
Methods: We screened 122 multiple drug resistant Acinetobacter baumannii (MDRAB) isolated from admitted
patients in one of the tertiary care hospital in Malaysia for the presence of antiseptic resistant genes qacA and qacE
(Quaternary Ammonium Compound) and susceptibility towards chlorhexidine (CLX), benzalkonium (BZK) and
benzethonium (BZT).
Results: Eighty-nine (73%) isolates harboured qacE gene, while none were positive for qacA. The MIC ranged from
0.2 to 0.6 for CLX, 0.02 to 0.2 for BZK and 0.04 to 0.2 μg/mL for BZT. The highest number of qacE positive isolates
were obtained from surgery (n = 24; 27%; p < 0.05), followed by medical ward (n = 23; 25.8%) and ICU (n = 21;
23.6%). Majority of the isolates from wound swabs (n = 33; 37%), T/aspirate (n = 16; 18%) and tissue (n = 10; 11.2%)
harboured the qacE genes.
Conclusion: The present investigation showed high prevalence of qacE gene among the studied isolates.
Antiseptics are important components of infection control, continuous monitoring of antiseptics use in the hospital
is cautioned.
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Multiple drug resistance Acinetobacter baumannii
(MDRAB) ranks top among the nosocomial pathogen
due to their environmental elasticity, ability to colonize
various body sites of hospitalized patients, long-time
persistence, association with multiple drug resistance
and their successful outbreak potential [1-5]. It causes a
wide spectrum of nosocomial infections which includes
infections of bloodstream, urinary and respiratory tract,* Correspondence: vasantha@upm.edu.my
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unless otherwise stated.and ventilator associated pneumonia commonly among
Intensive Care Unit patients (ICU) [6,7].
The main sources of transmission implicated with A.
baumannii infections are person to person contact or
through contaminated surface [8] and previous room
occupancy by patients with A. baumannii infection or
colonization. Epidemiological studies have clearly shown
that hospital environment and colonized patients as the
major reservoirs of A. baumannii infections [9]. Manage-
ment of A. baumannii infections is the greatest challenge
for patients, clinicians and infection control physicians.
Infection control interventions such as patient screening,
cohort isolation, hand hygiene compliance, surveillance of
environmental contamination, enhanced cleaning andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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nosocomial infection rates and outbreaks due to A.
baumannii in various studies [4,10,11].
Antiseptics are increasingly used in hospitals to con-
trol the dissemination of nosocomial infections. The
regular use of antiseptics in hospital has raised concerns
about its resistance. A very recent study by Suwantarat
[12] has shown that bacteria causing life threatening
infections in seriously ill patients are now becoming less
susceptible to the commonly used antiseptics in the hos-
pital. The study compared patients in ICU who received
daily antiseptic washes with non ICU patients who did
not receive any antiseptic baths. It was found that pa-
tients who received regular antiseptics baths showed less
susceptibility to CLX compared to those who did not
receive any antiseptic washes. Antiseptic resistance is
encoded by the qac genes. To date several qac genes
such as qac A/B genes [13-15], qac C/D also known as
smr [15], qacE/F [16,17], qacG [18], qacH [19,20], qac J
[21,22] and qac Z [23,24] have been reported. Qac A/B
followed by qac C/D genes is frequently associated with
gram positive [25] and [26], while qac E is commonly
seen in gram negative bacteria.
Several studies from Asia including Malaysia have
shown continuous increase of highly multiple drug re-
sistant A. baumannii in Asia [27-30]. A recent study
[27] demonstrated correlation between reduced suscepti-
bility to disinfectants and multidrug resistance among
clinical isolates of Acinetobacter species. Although sev-
eral studies have shown the prevalence of antibiotic
resistance in A. baumanni, only very few reports are
available on the antiseptic and disinfectant susceptibility.
In Malaysia, despite, A. baumannii being one of the ser-
ious nosocomial pathogen, its susceptibility towards an-
tiseptics and disinfectant is largely unknown. Therefore,
in this study we investigated the antiseptic and disinfect-
ant susceptibility and carriage of corresponding resistant
genes in A. baumannii isolated from patients admitted
in one of the tertiary care teaching hospital in Malaysia.
The study was conducted in Universiti kebangsan Malaysia
Medical Centre, as it is in the capital of the country,
which receives population from all over Malaysia. The
rising trends of A. baumannii infections in the hospital




A total of 122 non-repetitive multiple drug resistance
Acinetobacter baumannii (MDRAB) isolates collected from
various clinical specimens (5 from blood, 41 wound swabs,
26 tracheal aspirate, 14 urine, 14 tissue, 10 sputum, 12
from others) from February 2012 to January 2013 from
a 900 bedded hospital UKMMC was investigated. Theisolates were confirmed in the hospital by the stand-
ard microbiological methods and also by AP 20NE (bio-
Mérieux, France). The isolates were reconfirmed as A.
baumannii by standard methods (oxidase, catalase, TSI,
MRVP, Simmon citrate, motility, urease and Gram stain-
ing) in our laboratory stationed at Department of Medical
Microbiology and Parasitology, Faculty of Medicine and
Health Sciences, Universiti Putra Malaysia. An isolate is
defined as MDRAB when it is resistant to more than three
classes of antibiotics tested by disc diffusion test.
PCR assay for qacA and qacE
Total genomic DNA was extracted from MDRAB iso-
lates using GF-1 Bacterial DNA Extraction Kit (Vivantis
Technologies, Malaysia). All isolates were screened for
the presence of qacA [31] (5′GCAGAAAGTGCAGAG
TTCG-3′ and 5′ TCAACCGAATAGAGTGAACTTATC
T-3′) and qacE [32] (QacE F: 5′-GCGAAGTAATCGCA
ACATCC-3′ and Qac E R: 5′ GCCCCATACCTACAAA
GCC-3′) genes. Two representative isolates for each
gene was sequenced (First BASE Laboratories, Malaysia)
and used as positive control. The sequence of the genes
were confirmed by blastN program in GenBank (http://
www.ncbi.nlm.nih.gov).
Antiseptic susceptibility
All antiseptics chlorhexidine (CLX), benzalkonium (BZK)
and benzethonium (BZT) were purchased from Sigma
Aldrich (St Louis, MO, USA). A stock of antiseptics con-
taining 100 mg/L of CLX, BZK and BZT in deionized
water was prepared and stored at 4°C. MICs of antiseptics
were determined by the broth microdilution method ac-
cording to the Clinical and Laboratory Standards Institute
[1]. Since there was no standard breakpoints available for
antiseptics against A. baumannii, we tested a 2 fold dilu-
tions from 4% to 0.00006%. A standard bacterial concen-
tration of McFarland Standard 0.5 (1.5 × 108 CFU/mL)
was used. Briefly 50 μl of bacterial suspension was added
from well one to twelve in a 96 well plate. To well one,
50 μl of 4% antiseptics was added. Upon mixing well,
50 μl was transferred to next well and continued until last
well. The dilutions included 4%, 2%, 1%, 0.5%, 0.25%,
0.125%, 0.0625%, 0.0312%, 0.0156%, 0.0078%, 0.0039% and
0.0019%. Susceptibility was interpreted based on the
turbidity on the inoculum after incubation at 37°C for
24 hrs.
Results
Among the 122 isolates tested, qacE was found to be
present in 89 isolates (72.95%), none of the isolates
carried qacA gene. In general for qacA positive isolates,
the MIC ranged from 0.2 to 0.6 μg/mL for CLX, 0.02
to 0.2 μg/mL for BZK and 0.04 to 0.2 μg/mL for
BZT. For qacE negative isolates, MIC ranged from 0.04 to
Table 2 Isolation of qacE positive MDRAB from different
clinical specimens
Clinical specimens qacE positive (n = 89) P value
Tracheal aspirate 16 (18%) >0.05
Wound swabs 33 (37%) >0.05
Tissue 10 (11.2%) >0.05
Blood 4 (4.5%) >0.05
Urine 13 (14.6%) >0.05
Sputum 6 (6.8%) >0.05
Others 7 (7.9%) >0.05
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to 0.08 μg/mL for BZT. Highest qacE positive isolates
were obtained from surgery (n = 24; 27%), followed by
medical ward (n = 23; 25.8%) and ICU (n = 21; 23.6%) as
illustrated in Tables 1 and 2. Isolation of qacE positive
MDRAB was found to be significantly higher in the surgi-
cal ward (p < 0.05). Majority of the isolates from wound
swabs (n = 33; 37%), T/aspirate (n = 16/18%) and tissue
(n = 10/11.2%) harboured the qacE genes.
Discussion
MDRAB is the biggest challenge for the infection con-
trol unit in every hospital setting. Growing resistance to
every licensed antimicrobial agent against MDRAB in-
cluding carbapenems to date has made this organism of
global concern. Resistance rates may likely increase the
treatment failures and mortality rates [29,30]. Unfortu-
nate acquisition of MDRAB that leads to life threatening
blood stream infections and pneumonia in the hospital
could be prevented if proper hygienic measures are im-
plemented, practiced and monitored regularly.
Antiseptics are widely used for infection control. They
are applied to living tissue to reduce the possibility of
infection, sepsis, or putrefaction and especially to keep
the environment and the inanimate objects clean (for e.g.
ventilators, catheter) from microbial communities. In the
studied hospital, we found majority of the MDRAB
isolates 89 (73%) to harbour the qacE gene. However, the
MIC for all the QAC’s tested was far less than the con-
centration used in the hospitals (0.5%–4% mL/liter) [33].
A study [34] showed higher MIC for S. aureus that har-
boured qacA/B gene. In the current study for MDRAB, no
significant difference (p > 0.05) was observed in MIC for
qacE positive and negative isolates. The high carriage of
qacE positive MDRAB in surgical ward (p < 0.05) is not
surprising as it is known that antiseptics are very fre-
quently used in surgical wards to reduce the skin and soft
tissue infections and also to reduce the postsurgical lengthTable 1 Isolation of qacE positive MDRAB from different
wards
Ward Number of isolates (%)
qacE positive (n = 89) P value
ICU 21 (23.6%) >0.05
Neurosurgery 2 (2.2%) >0.05
Orthopaedics 7 (7.9%) >0.05
Urology 4 (4.5%) >0.05
Surgery 24 (27%) <0.05*
Medical 23 (25.8%) >0.05
Burn 2 (2.3%) >0.05
Others 6 (6.7%) >0.05
<0.05*Indicates statistically significant.of stay and duration of antibiotic therapy [3]. Central
venous (CV) catheters are commonly used in the ICU as
it plays crucial role in the management of critically ill
patients.
In the current study, we found that majority of MDRAB
isolates from ICU harbour qacE gene. Although the use of
antiseptic impregnated catheters reduces catheter related
bloodstream infections, emergence of antiseptic resistant
strains are still on the rise. A recent study [34] reported
high rates of qacA and qacB positive MRSA isolation from
chlorhexidine impregnated catheter related bloodstream
infections.
Stable resistance for antiseptics and antibiotics could
be obtained for MDRAB when they are exposed step-
wise with gradually increasing concentrations of QAC’s
as seen in Pseudomonas aeuroginosa and Eschericia coli
[34,12]. This has also been shown in a metagenomic
study which revealed that microbial community adapts
to QAC when continuously exposed. A recent review
has shown increasing evidence for co resistance and
cross resistance between QAC’s and other important
antibiotics and disinfectants.Limitations of the study
The main limitation of the study was samples from only
one hospital in Malaysia were studied. As very limited
data on antibiotic resistance pattern was available, anti-
septic and antibiotic resistance could not be compared.Conclusions
In conclusion, although the MIC of the QAC’s tested
against MDRAB is much lower than the concentration
used in the hospital, the high prevalence of qacE gene in
the studied isolates warns the continuous monitoring of
antiseptics use in the hospital.Competing interests
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